Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Jun Du, Jue Wang, Zi-Yu Feng, Lan Xu, Fei Xiao, Jia Liu, Dan Xiao, Wan-Bin Fu, Min-Yue Zhang, Li-Jing Shen, Lu Zhong, Hua Zhong, Jian Hou, Hong-Hui Huang, Ting Wang

Blood (2024) 144 (Supplement 1): 7729.

https://doi.org/10.1182/blood-2024-206799

Published: 2024

Journal Articles

A Case of Proliferative Glomerulonephritis with Monoclonal Kappa-Light Chain Deposits Treated with Daratumumab Combination Therapy

Jun Du, Jue Wang, JunTing Lv, Dan Xiao, Jia Liu, Lu Zhong

Blood (2024) 144 (Supplement 1): 6886.

https://doi.org/10.1182/blood-2024-206837

Published: 2024

Journal Articles

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Xingcheng Yang, Juan Peng, Lei Zhang, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2024) 144 (Supplement 1): 2935.

https://doi.org/10.1182/blood-2024-202707

Published: 2024

Journal Articles

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

Xiuiu Yang, Shanwei Ye, Qian Xu, Jue Wang, Caroline Markmann, Lingfeng Zhang, Shujia Zhang, Xinyue Deng, Jiali Cheng, Jia Wu, Vijay Bhoj, Zheng Zhang, Liang Huang

Blood (2024) 144 (Supplement 1): 89.

https://doi.org/10.1182/blood-2024-210125

Published: 2024

Journal Articles

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Yuhang Cheng, Xueyan Sun, Meijuan Huang, Lei Zhao, Jue Wang, Hanyu Wang, Wanying Liu, Shanwei Ye, Liang Huang, Gaoxiang Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 1447.

https://doi.org/10.1182/blood-2024-207442

Published: 2024

Journal Articles

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

Meijuan Huang, Lei Zhao, Yuhang Cheng, Liang Huang, Jianfeng Zhou, Dengju Li, Jue Wang, Yang Cao

Blood (2024) 144 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2024-197968

Published: 2024

Journal Articles

Evi1 Governs Kdm6b-Mediated Histone Demethylation to Regulate the Laptm4b-Driven mTOR Pathway in Hematopoietic Progenitor Cells

Qiong Wu, Chunjie Yu, Fang Yu, Yiran Guo, Yue Sheng, Liping Li, Yafang Li, Yutao Zhang, Chao Hu, Jue Wang, Tong-Chuan He, Yong Huang, Hongyu Ni, Zhigang Hou, Wenshu Wu, Greg G Wang, Jianxin Lyu, Zhijian Qian

Blood (2024) 144 (Supplement 1): 1337.

https://doi.org/10.1182/blood-2024-206390

Published: 2024

Journal Articles

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

Yuanyuan Zhang, Meijuan Huang, Tianjiao Liu, Yuhang Cheng, Dengju Li, Yang Cao, Wei Mu, Liting Chen, Li Zhu, Tongjuan Li, Liang Huang, Jia Wei, Lei Zhao, Jue Wang

Blood (2024) 144 (Supplement 1): 3419.

https://doi.org/10.1182/blood-2024-206731

Published: 2024

Journal Articles

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Xingcheng Yang, Juan Peng, Chunrui Li, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2023) 142 (Supplement 1): 1568.

https://doi.org/10.1182/blood-2023-190826

Published: 2023

Journal Articles

Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma

Jiali Cheng, Jue Wang, Xia Mao, Wei Mu, Shijia Sun, Xiaoxi Zhou, Liang Huang

Blood (2023) 142 (Supplement 1): 6863.

https://doi.org/10.1182/blood-2023-184370

Published: 2023

Journal Articles

Targeted Delivery of IL-12 Via CD19-Modified Extracellular Vesicles Enhances CAR-T Cell Efficacy Against Lymphoma

Meijuan Huang, Lei Zhao, Dengju Li, Liang Huang, Jue Wang, Yuanyuan Zhang

Blood (2023) 142 (Supplement 1): 6798.

https://doi.org/10.1182/blood-2023-180860

Published: 2023

Journal Articles

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

Blood (2023) 142 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2023-178624

Published: 2023

Journal Articles

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Qiuxia Yu, Daizi Gang, Jue Wang, Liang Huang, Chunrui Li, Yicheng Zhang, Xiaoxi Zhou, Yang Cao

Blood (2023) 142 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2023-180363

Published: 2023

Journal Articles

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

Blood (2023) 141 (11): 1265–1276.

https://doi.org/10.1182/blood.2022016362

Published: 2023

Includes: Supplemental data

Journal Articles

Allogeneic CAR-T Therapy Enabled By Base Editing of Lck to Resist Dasatinib Used to Prevent Rejection Mediated through Both T and NK in Host

Yuhang Cheng, Jiayuan Zhang, Xiaoqian Wang, Wenjie Dong, Xiaomin Yao, Yage Zhang, Juan Yang, Wei Mu, Jue Wang, Liang Huang, Guang Hu

Blood (2022) 140 (Supplement 1): 4556–4557.

https://doi.org/10.1182/blood-2022-169039

Published: 2022

Journal Articles

Updated Results of Fumanba-1: A Phase 1b/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood (2022) 140 (Supplement 1): 7435–7436.

https://doi.org/10.1182/blood-2022-166465

Published: 2022

Journal Articles

An External Control for Mosunetuzumab Using Real-World Data in Follicular Lymphoma in the Third or Subsequent Lines of Systemic Therapy

Sarah F. McGough, Natasha Shamas, Jue Wang, Mahmoud Jaber, Binay Swarup, Marie-Helene Blanchet Zumofen, Bertrand Lautié, Joana Parreira, Michael C. Wei, Ashwini Shewade

Blood (2022) 140 (Supplement 1): 3658–3660.

https://doi.org/10.1182/blood-2022-159640

Published: 2022

Journal Articles

Olverembatinib Based Therapy in Recurrent Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR/ABL Mutation

Qiuxia Lv, Qiuxia Yu, Yang Cao, Jue Wang, Yicheng Zhang, Gaoxiang Wang, Zhenya Hong, Li Meng

Blood (2022) 140 (Supplement 1): 11688–11689.

https://doi.org/10.1182/blood-2022-157416

Published: 2022

Journal Articles

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 547.

https://doi.org/10.1182/blood-2021-152576

Published: 2021

Journal Articles

SARS-CoV-2 infection induces the activation of tissue factor–mediated coagulation via activation of acid sphingomyelinase

Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao

Blood (2021) 138 (4): 344–349.

https://doi.org/10.1182/blood.2021010685

Published: 2021

Includes: Supplemental data

NARROW

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

A Case of Proliferative Glomerulonephritis with Monoclonal Kappa-Light Chain Deposits Treated with Daratumumab Combination Therapy

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

Superiority in the Longer Duration of Response and Better Central Nervous System Penetration of CAR-T Cell Therapy over Blinatumomab Infusion for Relapsed/ Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis

Type I Interferon Impairs the Function of CAR-T Cells By Disrupting Immune Synapse Assembly

Evi1 Governs Kdm6b-Mediated Histone Demethylation to Regulate the Laptm4b-Driven mTOR Pathway in Hematopoietic Progenitor Cells

Improving CAR-T Cell Function through a Targeted Cytokine Delivery System Utilizing CAR Target-Modified Extracellular Vesicles

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma

Targeted Delivery of IL-12 Via CD19-Modified Extracellular Vesicles Enhances CAR-T Cell Efficacy Against Lymphoma

Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

Allogeneic CAR-T Therapy Enabled By Base Editing of Lck to Resist Dasatinib Used to Prevent Rejection Mediated through Both T and NK in Host

Updated Results of Fumanba-1: A Phase 1b/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

An External Control for Mosunetuzumab Using Real-World Data in Follicular Lymphoma in the Third or Subsequent Lines of Systemic Therapy

Olverembatinib Based Therapy in Recurrent Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR/ABL Mutation

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

SARS-CoV-2 infection induces the activation of tissue factor–mediated coagulation via activation of acid sphingomyelinase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only